Lung Segmental Perfusion Defect Is Associated With Airway Complications After Living-Donor Lobar Lung Transplantation Authors: Kentaro Imanishi, Seiichiro Sugimoto, Tsuyoshi Ryuko, Yasuaki Tomioka, Shin Tanaka, Ken Suzawa, Kazuhiko Shien, Kentaroh Miyoshi, Mikio Okazaki, Shinichi Toyooka Published: 2026 ABSTRACT AbstractPURPOSEAirway complications (ACs) are potentially fatal after lung transplantation (LT). Although bronchial blood flow to the graft is supplied mainly from the pulmonary circulation after LT, lung segmental perfusion defects (LSPDs) are occasionally identified on lung perfusion scintigraphy (Q-scinti) after living-donor lobar LT (LDLLT). Lung segmental perfusion defects may impair bronchial healing and contribute to the development of ACs. This study aimed to evaluate the relationship between LSPD and AC after LDLLT.METHODSWe retrospectively reviewed 86 recipients who underwent LDLLT and 163 living donors at our institution from October 1998 to December 2023. Transplanted lungs that developed AC were classified as the AC group, whereas those without AC were classified as the non-AC group. Blood flow in the transplanted lungs was evaluated using Q-scinti after LDLLT.RESULTSAC developed in 8 (4.9%) of 163 transplanted lungs after LDLLT. Although there were no significant differences in recipient-related variables between the 2 groups, LSPD was detected significantly more frequently in the AC group (n = 8) than in the non-AC group (n = 155) (50.0% vs 6.5%, P = .002). Furthermore, transplanted lungs showing LSPD were associated with significantly higher grades of the pulmonary interlobar fissures at the time of living-donor lobectomy (P = .025). Overall survival did not differ between patients with and without AC after LDLLT.CONCLUSIONSLSPD on Q-scinti, which may develop in grafts with incomplete interlobar fissures during living-donor lobectomy, is associated with the development of AC after LDLLT.CLINICAL REGISTRATION NUMBERThis study was approved by the Institutional Review Board of Okayama University Hospital (approval date: August 23, 2024; 2409-027).Keywords: airway complication, interlobar fissure, living-donor lobar lung transplantation, lung perfusion scintigraphy, lung transplantation INTRODUCTION Lung transplantation (LT) is a well-established treatment for end-stage lung disease. Despite advances in lung preservation methods, surgical techniques, and perioperative management, airway complications (ACs) remain among the most serious complications after LT.1 Indeed, patients who develop ACs have been shown to have worse survival than those without AC after LT.2 Several risk factors for AC after LT have been reported, including male sex, inadequate lung preservation, prolonged donor mechanical ventilation, telescoping anastomosis, primary graft dysfunction (PGD), and acute rejection.3–7 However, risk factors for AC after living-donor lobar LT (LDLLT) remain unclear because of the limited number of procedures performed worldwide. Living-donor lobar LT is considered an alternative to deceased-donor lung transplantation (DDLT) in countries experiencing severe donor shortages, such as Japan.8 Adequate blood supply to the bronchial anastomosis is essential for optimal bronchial healing, and ischaemia of the graft bronchus is regarded as the primary cause of ACs.9 Because the bronchial arterial circulation is interrupted at the bronchial division in the recipient, bronchial blood flow to the graft depends predominantly on retrograde perfusion from the recipient’s pulmonary artery.7 Therefore, reductions in blood flow to the transplanted lung may contribute to the development of ACs after LT. Lung perfusion scintigraphy (Q-scinti) is widely used to evaluate postoperative pulmonary blood flow after both DDLT and LDLLT and is also useful for diagnosing chronic lung allograft dysfunction (CLAD).10–12 Interestingly, Q-scinti occasionally demonstrates lung segmental perfusion defects (LSPDs), predominantly in the superior segment of transplanted lobar grafts after LDLLT. Such findings indicate localized reductions in blood flow within the graft and may therefore predispose patients to ACs. However, the relationship between LSPD and the development of AC after LDLLT remains unclear. Accordingly, this study aimed to investigate the association between LSPD on Q-scinti and the occurrence of AC, as well as to characterize the features of LSPD after LDLLT. METHODS Patients We retrospectively analysed a cohort of patients who underwent LDLLT at Okayama University Hospital between October 1998 and December 2023. Recipients who underwent nonstandard LDLLT procedures were excluded, including 1 patient with middle-lobe LT, 3 who underwent segmental LT, and 2 who received hybrid LT combining with unilateral DDLT and LDLLT, as well as recipients who did not undergo Q-scinti after LDLLT. Ultimately, 86 recipients who underwent standard LDLLT using lower-lobe grafts and 163 living donors were included in this study. Preoperative and operative characteristics and postoperative outcomes were assessed. Airway complications were defined as bronchial complications requiring bronchoscopic or surgical intervention. Transplanted lungs that developed ACs were classified as the AC group, whereas those without ACs were classified as the non-AC group. Overall survival was defined as the interval from LDLLT to death or the last follow-up. The study protocol (No. 2409-027) was approved by the institutional review board of Okayama University Hospital on August 23, 2024. The requirement for patient consent was waived because of the retrospective nature of the study, and patients were informed of their right to opt out. This study was conducted in accordance with the Declaration of Helsinki. Donor and recipient selection and the procedures of LDLLT Living-donor lobar LT is indicated for critically ill patients who cannot wait for DDLT. All LDLLT recipients were required to meet the criteria for DDLT registration with the Japan Organ Transplantation Network. Only blood relatives within the third degree or spouses were permitted as living donors at our institution. Living donors underwent lung ventilation scintigraphy and Q-scinti preoperatively to confirm normal ventilation and perfusion distribution. During donor lobectomy, pulmonary interlobar fissures were classified into 4 grades according to Craig’s classification (Figure 1): Grade 1, complete fissure with entirely separate lobes; Grade 2, complete visceral cleft but parenchymal fusion at the base of the fissure; Grade 3, visceral cleft evident for part of the fissure; Grade 4, complete fusion of the lobes with no evident fissural line.13 The LDLLT procedure has been described previously.14,15 The grade was extracted from the operative records by 2 surgeons (K.I. and S.S.). Bronchial anastomosis was performed using either an end-to-end or telescoping technique, depending on bronchial size mismatch. Running sutures were used for the membranous portion and interrupted sutures for the cartilaginous portion, or alternatively, running sutures were applied to both portions.14 Bronchial artery revascularization was not performed. The graft ischaemic time of the second lung was defined as the ischaemic time following bilateral LDLLT. Schematic Illustration of the Grade of Interlobar Fissures according to Craig’s Classification:13 Grade 1, Complete Fissure with Entirely Separate Lobes; Grade 2, Complete Visceral Cleft but Parenchymal Fusion at the Base of the Fissure; Grade 3, Visceral Cleft Evident for Part of the Fissure; Grade 4, Complete Fusion of the Lobes With No Evident Fissural Line. Postoperative care Postoperative management of LDLLT recipients, including immunosuppressive and prophylactic therapies, has been described elsewhere.16 Patients received triple immunosuppressive therapy consisting of tacrolimus or cyclosporine, mycophenolate mofetil or azathioprine, and corticosteroids. Primary graft dysfunction was graded according to the definition proposed by the International Society for Heart and Lung Transplantation (ISHLT).17 Surveillance bronchoscopy was performed during the early postoperative period and when clinically relevant ACs were suspected.18 Q-scinti was performed following intravenous administration of 185 MBq of technetium-99m macroaggregated albumin (99mTc-MAA; Techne MAA kit, Fujifilm, Japan) in the supine position before hospital discharge after LDLLT and annually thereafter.12 Lung segmental perfusion defect was defined as a clear segmental blood-flow defect without perfusion on Q-scinti, as shown in Figure 2. Pulmonary function tests were conducted at 3, 6, 12 months and annually after LDLLT. CLAD was diagnosed based on a consensus report from the ISHLT.19 Representative Cases Showing Normal Lung Perfusion (A) and a Lung Segmental Perfusion Defect (LSPD) in the Right Superior Segment (B) of Lobar Lung Grafts on Lung Perfusion Scintigraphy after Living-Donor Lobar Lung Transplantation. Statistical analysis All statistical analyses were performed using EZR (Saitama Medical Center, Jichi Medical University, Saitama, Japan), a graphical user interface for R (The R Foundation for Statistical Computing).20 Continuous variables were presented as medians with ranges, and between-group differences were assessed using the Mann–Whitney U-test. Categorical variables were compared using the Fisher’s exact test. Missing data were not replaced. Survival rates were estimated using the Kaplan–Meier method and compared using the log-rank test. Statistical significance was defined as P < .05. RESULTS Airway complication developed in 8 lobar lung grafts (the AC group) from 8 recipients but did not occur in 155 lobar lung grafts (the non-AC group) from 78 recipients after LDLLT. Table 1 summarizes the recipient characteristics with and without AC. There were no significant differences in known risk factors for AC, including male sex, PGD, or the incidence of acute rejection, between the 2 groups, nor in the other recipient variables.3–7 All 8 recipients in the AC group exhibited bronchial stenosis alone, without dehiscence or malacia, in the lobar to segmental bronchi after LDLLT (Figure 3). Airway complication developed on the right side in 4 recipients (2 at the bronchial anastomosis, 1 in the basal segmental bronchi [B7-10], and 1 in the B8-9 segmental bronchi) and on the left side in 4 recipients (3 at the bronchial anastomosis and 1 in the basal segmental bronchi [B8-10]). Table 1.Recipient CharacteristicsVariablesNon-AC (n = 78)AC (n = 8) P-value Preoperative variables Age (range)27.50 (5-68)40.5 (13-64).22 Sex, male (%)24 (30.8)4 (50.0).429 Past smoker, yes (%)7 (10.0)2 (25.0).229 Body mass index (range)16.59 (10.50-26.75)18.58 (15.03-29.00).108Diagnoses Pulmonary hypertension (%)23(29.5)1 (12.5).433 Interstitial pneumonia (%)21 (26.9)2 (25.0).702 Graft-versus-host disease (%)16 (20.5)3 (37.5).367 Chronic lung allograft dysfunction (%)2 (2.6)1 (12.5).271 Others (%)16 (20.5)1 (12.5)1 CMV mismatch (recipient negative/donor positive), yes (%)11 (14.1)0 (0.0).589 Preoperative steroid administration, yes (%)40 (51.3)3 (37.5).713 Total number of HLA mismatches (range)5 (0-11)6.50 (3-9).14 Preoperative tracheostomy, yes (%)9 (11.5)1 (12.5)1 Operative variables Total ischaemic time, minute (range)164.5 (74-243)187 (142-279).05 Cardiopulmonary bypass, yes (%)73 (93.6)8 (100.0)1Lung transplant procedure (%) Single10 (12.8)0 (0.0).588 Bilateral68 (87.2)8 (100.0) Anastomosis wrapping, yes (%)12 (15.4)0 (0.0).593 Postoperative variables Postoperative ECMO, yes (%)2 (2.6)0 (0.0)1 P/F ratio after ICU admission (range)388.25 (71.5-579.0)425.0 (269-575).412 Maximum grade of PGD (0-72 h)1 (0-3)0.5 (0-2).737 Acute rejection, yes (%)49 (62.8)5 (62.5)1 Duration of mechanical ventilation, days (range)10.00 (2-265)26.5 (4-68).095 Postoperative tracheostomy, yes (%)29 (38.2)5 (62.5).26 Postoperative GERD, yes (%)2 (2.6)0 (0.0)1 CLAD, yes (%)32 (41.0)2 (25.0).47Data are presented as n (%) or median (range).Abbreviations: AC, airway complication; CMV, cytomegalovirus; ECMO, extracorporeal membrane oxygenation; GERD, gastroesophageal reflex disease; HLA, human leucocyte antigen; ICU, intensive care unit; P/F, PaO2/FiO2; PGD, primary graft dysfunction. Recipient Characteristics Data are presented as n (%) or median (range). Abbreviations: AC, airway complication; CMV, cytomegalovirus; ECMO, extracorporeal membrane oxygenation; GERD, gastroesophageal reflex disease; HLA, human leucocyte antigen; ICU, intensive care unit; P/F, PaO2/FiO2; PGD, primary graft dysfunction. Representative Case of an Airway Complication after Living-Donor Lobar Lung Transplantation (LDLLT). (A) Right bronchial anastomosis after LDLLT. (B) Stenosis of the right basal segmental bronchus. (C) After stent placement for bronchial stenosis. As shown in Table 2, graft characteristics from living donors did not differ in the preoperative and operative variables, such as the number of HLA mismatches or the anastomotic type, between the non-AC group (n = 155) and the AC group (n = 8). In contrast, the AC group showed a significantly higher rate of LSPD on Q-scinti than the non-AC group (50.0% vs 6.5%, P = .002). Table 2.Graft CharacteristicsVariablesNon-AC (n = 155)AC (n = 8) P-value Preoperative variables Age (range)38 (20-61)41.5 (30-53).265 Sex, male (%)77 (49.7)7 (87.5).065 Past smoker, yes (%)73 (47.1)4 (50.0)1 Total number of HLA mismatches (range)3 (0-6)3 (2-6).622 Operative variables Anastomotic type End-to-end (%)112 (72.3)7 (87.5).684 Telescoping (%)43 (27.7)1 (12.5) Anastomotic procedure Running suture and interrupted suture (%)73 (47.1)3 (37.5).725 Running suture (%)82 (52.9)5 (62.5) Postoperative variables LSPD on Q-scinti, yes (%)10 (6.5)4 (50.0).002Data are presented as n (%) or median (range).Abbreviations: AC, airway complication; HLA, human leucocyte antigen; LSPD, lung segmental perfusion defect; Q-scinti, lung perfusion scintigraphy. Graft Characteristics Data are presented as n (%) or median (range). Abbreviations: AC, airway complication; HLA, human leucocyte antigen; LSPD, lung segmental perfusion defect; Q-scinti, lung perfusion scintigraphy. To evaluate the characteristics of LSPD, graft features according to the presence or absence of LSPD on Q-scinti are shown in Table 3. Lung segmental perfusion defect was observed in 14 of 163 grafts (8.6%) after LDLLT and occurred exclusively in the superior segment (S6), not in other basal segments of the lobar lung grafts. Grafts with LSPD (n = 14) had a significantly higher proportion of male donors than those without LSPD (n = 149) (P = .049). Notably, the grade of pulmonary interlobar fissures was significantly higher in grafts with LSPD than in those without LSPD (P = .025), indicating more fused interlobar fissures at the time of living donor lobectomy. In contrast, there were no significant differences in the number of staplers used to divide the interlobar fissure or in intraoperative blood loss. Table 3.Graft Characteristics According to the Presence or Absence of LSPD on Q-ScintiVariablesNon-LSPD (n = 149)LSPD (n = 14) P-value Preoperative variables Age (range)39 (20-61)35.5 (23-53).29 Sex, male (%)73 (49.0)11 (78.6).049 Past smoker, yes (%)71 (47.7)6 (42.9).786 Operative variables Grade of pulmonary fissures (range)1 (1-3)2 (1-3).025 Number of staplers used for dividing the interlobar fissure (range)1 (0-8)1.5 (0-6).249 Blood loss during living donor lobectomy, mL (range)200.0 (0-4350)155.0 (60-395).745 Postoperative variables Chronic lung allograft dysfunction, yes (%)35 (23.5)2 (14.3).738Data are presented as n (%) or median (range).Abbreviations: LSPD, lung segmental perfusion defect; Q-scinti, lung perfusion scintigraphy. Graft Characteristics According to the Presence or Absence of LSPD on Q-Scinti Data are presented as n (%) or median (range). Abbreviations: LSPD, lung segmental perfusion defect; Q-scinti, lung perfusion scintigraphy. Although overall survival tended to be lower in patients with AC, there was no significant difference in survival between patients with and without AC after LDLLT (P = .462) (Figure 4). Overall Survival Did Not Differ between Recipients With and Without Airway Complications After Living-Donor Lobar Lung Transplantation (5-Year Survival, 71.4% vs 84.2%; 10-Year Survival, 57.1% vs 74.7%; 15-Year Survival, 57.1% vs 62.7%) (P = .462). DISCUSSION In this study, we found that the lobar lung grafts which developed AC had a significantly higher incidence of LSPD on Q-scinti than those that did not after LDLLT, although there were no significant differences in recipient characteristics between patients with and without AC. Moreover, lobar lung grafts showing LSPD after LDLLT had a significantly higher grade of pulmonary interlobar fissures at the time of living-donor lobectomy, indicating more fused interlobar fissures. In addition, overall survival did not differ according to the presence or absence of AC after LDLLT. These findings suggest that LSPD on Q-scinti, which may develop more frequently in the lobar lung grafts with incomplete interlobar fissures during living-donor lobectomy, could be associated with the development of AC after LDLLT. To the best of our knowledge, this is the first report describing LSPD image findings on Q-scinti after LDLLT as well as the relationship between LSPD and ACs following LT. Lung segmental perfusion defect was occasionally encountered (8.6%) and was observed exclusively in S6 of lower-lobe grafts after LDLLT. Furthermore, in the present study, lobar lung grafts with AC had a significantly higher incidence of LSPD than those without AC. Anatomically, bronchial healing depends on blood flow from the bronchial arteries.9 After LT, bronchial arterial perfusion of the graft is maintained primarily through retrograde flow from the pulmonary artery.21–23 Lung segmental perfusion defect reflects a segmental loss of pulmonary perfusion, suggesting a reduction in this retrograde flow to the bronchial circulation after LDLLT. Such a decrease in blood supply may impair bronchial healing and thereby contribute to the development of AC. Moreover, our results indicate that LSPD in S6 does not directly cause AC in B6 but may indirectly affect the development of AC at the bronchial anastomosis site and in the basal segmental bronchi. Similar to AC after DDLT, AC after LDLLT may tend to develop in the basal segmental bronchi on the mediastinal side of the bronchial anastomosis. This may be attributed to anatomical characteristics: the distance from the bronchial anastomosis site to the lung parenchyma is longer in the basal segmental bronchi than in B6. Therefore, AC in the basal segmental bronchi may be influenced by reduced blood flow related to the longer bronchial length on the mediastinal side, as well as by compensatory flow redistribution to B6. One concern is the timing of LSPD onset. Because Q-scinti was routinely performed before hospital discharge after LDLLT, the precise timing of LSPD development could not be determined in this study. It is possible that AC itself led to reduced blood flow and thereby influenced the appearance of LSPD on Q-scinti. However, given that 50% of recipients with AC did not demonstrate LSPD, it is unlikely that LSPD was solely a consequence of AC. Except for the incidence of LSPD on Q-scinti, we found no difference in established risk factors for AC after DDLT3–7 between patients with and without AC after LDLLT. The effect of PGD on AC may be attenuated after LDLLT because PGD grades tend to be lower than after DDLT owing to the shorter ischaemic times associated with LDLLT.14 Living-donor lobar LTs using lobar grafts from adult living donors are performed mainly in small recipient, such as children and adult women; consequently, the proportion of male recipients was relatively low in this cohort. Bronchial telescoping anastomosis, a potential risk factor for AC after DDLT,1,24 did not influence the development of AC after LDLLT, nor did the bronchial suturing technique (running vs interrupted sutures).25 Regarding postoperative variables, the duration of mechanical ventilation tended to be longer in recipients with AC, likely as a result of AC development. Compared with AC after DDLT, AC after LDLLT is characterized by involvement of the lobar to segmental bronchi, consists exclusively of bronchial stenosis rather than necrosis, and often requires earlier intervention.14 These characteristics may contribute to deterioration of respiratory status and long duration of mechanical ventilation early after LDLLT. Lobar lung grafts that demonstrated LSPD after LDLLT had more fused interlobar fissures at the time of living-donor lobectomy. Our findings suggest that LSPD may be attributable to surgical dissection of incomplete fissures, as all living donors had normal lung perfusion before the donation. In living-donor lobectomy, incomplete interlobar fissures must be divided, usually with staplers, to prevent postoperative air leakage in recipients. However, such fissures are known to contain translobar bronchovascular structures at a relatively high frequency.26 Consequently, vessels supplying the superior segment of the lower lobe, including translobar or subsegmental branches, may be inadvertently compromised during stapler division of incomplete fissures. Although division of translobar vessels is unavoidable during lobectomy, careful use of electrocautery and vessel-sealing devices may help preserve subsegmental vessels and minimize stapler use when dissecting incomplete fissures. At our institution, 3D CT angiography is routinely used to obtain detailed bronchovascular anatomical information preoperatively. In this study, grafts with Grade 1-3 fissures were accepted for LDLLT, whereas grafts with complete fissure failure or absent fissures (Grade 4) were excluded. Based on our experience, potential donors with absent interlobar fissures, which can be identified on preoperative CT,27 should not be considered suitable candidates for donation. Interestingly, LSPD was observed only in the superior segment and not in the basal segments of the lobar grafts. This may reflect the fact that the superior segment has less extensive branching than the basal segments of the lower lobe.28 Because Q-scinti is performed in the supine position, gravitational effects were considered unlikely to account for the observed distribution of LSPD. In addition, a possible mechanism of LSPD formation is that the pulmonary artery branch to the superior segment is relatively small and may be susceptible to kinking after graft ventilation. Overall survival tended to be lower in recipients with AC, although the difference was not statistically significant, and the incidence of CLAD did not differ between the groups. This trend towards poorer survival may be attributable to limited bronchoscopic treatment options for AC after LDLLT, as AC typically involves small airways, namely the lobar to segmental bronchi.14,29 To address this issue, we have applied metallic vascular stents for the treatment of AC after LDLLT.18,30 Further innovations in bronchoscopic intervention may help improve outcomes even in recipients who develop AC after LDLLT. This study has several limitations. First, it was a single-centre retrospective analysis with a limited sample size, and confirmation in larger multicentre cohorts is warranted. Second, lung perfusion was assessed only by Q-scinti, as contrast-enhanced CT was avoided to reduce the risk of acute kidney injury and chronic kidney disease after LDLLT. Third, in some recipients, Q-scinti was performed after AC had already developed because AC tends to occur earlier after LDLLT than after DDLT. Given the limited number of events, these results should be interpreted as exploratory and hypothesis-generating rather than definitive. Nevertheless, because LDLLT is performed in relatively few centres worldwide, particularly outside Japan, this study provides clinically relevant information regarding the association between LSPD and AC after LDLLT. In conclusion, lobar lung grafts that developed AC had a higher incidence of LSPD on Q-scinti after LDLLT, and LSPD may be associated with the development of AC. Lobar grafts demonstrating LSPD also had more fused pulmonary interlobar fissures at the time of living-donor lobectomy. Careful dissection of incomplete fissures may therefore contribute to preventing AC after LDLLT. ACKNOWLEDGEMENTS During the preparation of this work, the authors used ChatGPT [https://chatgpt.com/] in order to improve language and readability. After using this tool/service, the authors reviewed and edited the content as needed and take full responsibility for the content of the publication. Glossary Abbreviations airway complication chronic lung allograft dysfunction computed tomography deceased-donor lung transplantation the International Society for Heart and Lung Transplantation living-donor lobar lung transplantation lung segmental perfusion defect lung transplantation primary graft dysfunction lung perfusion scintigraphy Contributor Information Kentaro Imanishi, Department of General Thoracic Surgery and Breast and Endocrinological Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, 700-8558, Japan. Seiichiro Sugimoto, Department of General Thoracic Surgery and Breast and Endocrinological Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, 700-8558, Japan; Department of General Thoracic Surgery and Organ Transplant Center, Okayama University Hospital, Okayama, 700-8558, Japan. Tsuyoshi Ryuko, Department of General Thoracic Surgery and Breast and Endocrinological Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, 700-8558, Japan; Department of General Thoracic Surgery and Organ Transplant Center, Okayama University Hospital, Okayama, 700-8558, Japan. Yasuaki Tomioka, Department of General Thoracic Surgery and Breast and Endocrinological Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, 700-8558, Japan. Shin Tanaka, Department of General Thoracic Surgery and Breast and Endocrinological Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, 700-8558, Japan; Department of General Thoracic Surgery and Organ Transplant Center, Okayama University Hospital, Okayama, 700-8558, Japan. Ken Suzawa, Department of General Thoracic Surgery and Breast and Endocrinological Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, 700-8558, Japan. Kazuhiko Shien, Department of General Thoracic Surgery and Breast and Endocrinological Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, 700-8558, Japan. Kentaroh Miyoshi, Department of General Thoracic Surgery and Breast and Endocrinological Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, 700-8558, Japan. Mikio Okazaki, Department of General Thoracic Surgery and Breast and Endocrinological Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, 700-8558, Japan. Shinichi Toyooka, Department of General Thoracic Surgery and Breast and Endocrinological Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, 700-8558, Japan; Department of General Thoracic Surgery and Organ Transplant Center, Okayama University Hospital, Okayama, 700-8558, Japan. AUTHOR CONTRIBUTIONS K.I., S.S. designed this study, conducted data analysis and interpretation, and participated in writing the paper. K.I., S.S., T.R., Y.T., S.T., K.M. participated in the data collection. All authors contributed to the writing of the manuscript and approved the final version. FUNDING This work was supported by a Grant-in-Aid for Scientific Research (Grant no. 25K02729) from the Japan Society for the Promotion of Science. CONFLICTS OF INTEREST The authors declare that they have no conflicts of interest. DATA AVAILABILITY Data are available from the corresponding author upon reasonable request. REFERENCES Associated Data Data Availability Statement Data are available from the corresponding author upon reasonable request.